Andromeda is an integrated digital healthcare platform, operating within the B2B2C space, with a focus on uninterrupted patient journeys, inter-operability, efficiency and equity. The company's mission is to bring health directly into the hands of individuals, whether it's for themselves, their children, or their families. Their ultimate goal is to support an uninterrupted journey towards a better life by leveraging technology to empower individuals to take control of their health despite any limitations. The company's approach involves connecting people and organizations, and equipping them with cutting-edge technologies to build an integrated community around the healthcare ecosystem. This results in an independent, fully-integrated digital healthcare platform for everyone, offering a digitalized and uninterrupted customer journey throughout the entire healthcare ecosystem. Founded in 2022 and headquartered in the United States, Andromeda focuses on the Information Technology and Internet industries. The company aims to create unique and seamless journeys for all consumers within the entire ecosystem. Despite not having publicly disclosed their last investment details and investors, Andromeda's commitment to revolutionizing the healthcare industry through digitalization and integration presents an exciting opportunity for potential venture capital investors seeking to support innovative solutions in the healthcare space. The company's dedication to building a tech-driven, patient-centric platform aligns with industry trends and demands, making it an intriguing prospect for funding.
There is no investment information
No recent news or press coverage available for Andromeda.